Private Placement

Naples-based Florida Sell Now is leveraging private investment to move beyond 'flipping' and tackle complex real estate deals statewide.

A new report reveals mid-market firms are ditching one-size-fits-all tech, embracing hybrid IT, and using AI to build resilient, value-driven futures.

How a nearly 40-year-old private company consistently outmaneuvers rivals, securing top ranks on Forbes' list and leading the global memory industry.

A novel cell therapy for Parkinson's earns a key FDA designation, signaling a potential paradigm shift from managing symptoms to reversing the disease.

With a $200M boost from Digital Alpha and a Cisco partnership, this Australian Neocloud is set to power the region's AI ambitions on a sovereign platform.

The nation attracted 67 advanced FDI projects in 2025, but emerging signs of a slowdown and global competition test its long-term competitiveness.

A new report forecasts a 55% CAGR for Wi-Fi 7, a technological leap set to redefine everything from home entertainment to industrial automation.

An Abu Dhabi startup won a global challenge with a novel solution that turns desert into farmland in one month, promising a new era for food security.

At a major San Francisco summit, Chinese biotechs unveiled breakthrough heart and cancer drugs, signaling a strategic shift from manufacturing to global innovation.

With a fresh $2.5 million in capital, AlphaGen Intelligence Corp. is poised to expand its 3D content and AI platforms in a competitive tech landscape.

CryptoStar extends its crucial $2.25M funding round again, relying heavily on insider investment to fuel a risky but necessary pivot from crypto to AI.

Corvus Pharmaceuticals is set to unveil pivotal early data for its novel eczema drug, soquelitinib, a moment analysts call a critical milestone.

As visa backlogs mount, one firm's $1B capital raise and $300M repayment record highlights a shift toward investor security in immigration investment.

The state's popular 20% down payment assistance program is back. Here’s a guide for first-generation buyers on how to navigate the lottery system.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.

A new 26-storey tower will add 280 long-term care beds and modern clinics, funded by an innovative philanthropic model that could reshape Canadian healthcare.

LiberNovo's new Moss Green Omni chair targets the restorative work trend, combining advanced dynamic ergonomics with a nature-inspired aesthetic and fabric.

With a final $4.6M in funding and 290 tons of free scrap, IperionX is scaling up a green, domestic titanium supply chain for America's defense.

Canadian battery innovator NEO Battery Materials secures new capital to scale up its silicon anode production, targeting the booming drone, EV, and robotics markets.

Billionaire investor Eric Sprott's lead order in REV Exploration's $5.8M financing validates its unique strategy in both Quebec gold and natural hydrogen.